Pilot Study of an Anti-Epidermal Growth Factor Receptor (EGFR) Antibody, Cetuximab, in Combination With Irinotecan, Fluorouracil, and Leucovorin [folinic acid], and in Patients With Newly Diagnosed Stage IV Colorectal Carcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cetuximab; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Jun 2013 Biomarkers information updated
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2005 New trial record.